Oncogenic properties of HIV-tat in colorectal cancer cells

Duy Huynh, Elizabeth Vincan, Theo Mantamadiotis, Damian Purcell, Chee Kai Chan, Robert Ramsay

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

With the advent of Highly-Active-Anti-Retroviral-Therapy (HAART), HIV patients can expect to live beyond 10-15 years following diagnosis. An unexpected result of increased survival is the emergence of opportunistic, oncogenic virus-associated cancers such as Burkitt's lymphoma (Epstein-Barr Virus), cervical cancer (Human Papilloma Virus) and Kaposi's sarcoma (Kaposi's sarcoma-associated herpesvirus) in this immuno-compromised population. Furthermore, there are reports of colorectal cancers (CRC) in long-term HIV-AIDS survivors. Compared to the general, non-immunocompromised population, long-term AIDS patients have 4 and 3.3-fold increased risk of developing colorectal and anorectal cancer respectively. Unlike oncogenic virus-associated cancers, CRC is not known to have a viral etiology. Our study aimed to investigate one aspect of HIV infection and colorectal carcinogenesis. We proposed that the HIV transactivator protein Tat; a protein with known oncogenic properties that is secreted and can re-enter non-infected cells may have a role in CRC. Using two CRC cell lines, LIM1215 and LIM2537 we found that Tat inhibits epithelial cyto-differentiation, blocks apoptosis in vitro and accelerates tumour formation in vivo. In addition, Tat significantly increases in vitro migration in the absence of foetal calf serum. These properties underpin CRC, and as HIV infection is initiated in the gut lymphoid system, these data provide a basis for the increased incidence of CRC in long term AIDS patients.

Original languageEnglish
Pages (from-to)403-409
Number of pages7
JournalCurrent HIV Research
Volume5
Issue number4
DOIs
Publication statusPublished - Jul 2007
Externally publishedYes

Fingerprint

Colorectal Neoplasms
HIV
HIV Long-Term Survivors
Oncogenic Viruses
Papillomaviridae
Human Immunodeficiency Virus rev Gene Products
HIV Infections
Acquired Immunodeficiency Syndrome
Human Herpesvirus 8
Neoplasms
Burkitt Lymphoma
Kaposi's Sarcoma
Human Herpesvirus 4
Information Systems
Uterine Cervical Neoplasms
Population
Carcinogenesis
Apoptosis
Cell Line
Survival

Keywords

  • Colon cancer
  • HAART
  • HIV-1
  • Oncogene
  • Tat

ASJC Scopus subject areas

  • Infectious Diseases

Cite this

Huynh, D., Vincan, E., Mantamadiotis, T., Purcell, D., Chan, C. K., & Ramsay, R. (2007). Oncogenic properties of HIV-tat in colorectal cancer cells. Current HIV Research, 5(4), 403-409. https://doi.org/10.2174/157016207781023974

Oncogenic properties of HIV-tat in colorectal cancer cells. / Huynh, Duy; Vincan, Elizabeth; Mantamadiotis, Theo; Purcell, Damian; Chan, Chee Kai; Ramsay, Robert.

In: Current HIV Research, Vol. 5, No. 4, 07.2007, p. 403-409.

Research output: Contribution to journalArticle

Huynh, D, Vincan, E, Mantamadiotis, T, Purcell, D, Chan, CK & Ramsay, R 2007, 'Oncogenic properties of HIV-tat in colorectal cancer cells', Current HIV Research, vol. 5, no. 4, pp. 403-409. https://doi.org/10.2174/157016207781023974
Huynh, Duy ; Vincan, Elizabeth ; Mantamadiotis, Theo ; Purcell, Damian ; Chan, Chee Kai ; Ramsay, Robert. / Oncogenic properties of HIV-tat in colorectal cancer cells. In: Current HIV Research. 2007 ; Vol. 5, No. 4. pp. 403-409.
@article{fee4d3bbc8d848a6808fa16e3d557eac,
title = "Oncogenic properties of HIV-tat in colorectal cancer cells",
abstract = "With the advent of Highly-Active-Anti-Retroviral-Therapy (HAART), HIV patients can expect to live beyond 10-15 years following diagnosis. An unexpected result of increased survival is the emergence of opportunistic, oncogenic virus-associated cancers such as Burkitt's lymphoma (Epstein-Barr Virus), cervical cancer (Human Papilloma Virus) and Kaposi's sarcoma (Kaposi's sarcoma-associated herpesvirus) in this immuno-compromised population. Furthermore, there are reports of colorectal cancers (CRC) in long-term HIV-AIDS survivors. Compared to the general, non-immunocompromised population, long-term AIDS patients have 4 and 3.3-fold increased risk of developing colorectal and anorectal cancer respectively. Unlike oncogenic virus-associated cancers, CRC is not known to have a viral etiology. Our study aimed to investigate one aspect of HIV infection and colorectal carcinogenesis. We proposed that the HIV transactivator protein Tat; a protein with known oncogenic properties that is secreted and can re-enter non-infected cells may have a role in CRC. Using two CRC cell lines, LIM1215 and LIM2537 we found that Tat inhibits epithelial cyto-differentiation, blocks apoptosis in vitro and accelerates tumour formation in vivo. In addition, Tat significantly increases in vitro migration in the absence of foetal calf serum. These properties underpin CRC, and as HIV infection is initiated in the gut lymphoid system, these data provide a basis for the increased incidence of CRC in long term AIDS patients.",
keywords = "Colon cancer, HAART, HIV-1, Oncogene, Tat",
author = "Duy Huynh and Elizabeth Vincan and Theo Mantamadiotis and Damian Purcell and Chan, {Chee Kai} and Robert Ramsay",
year = "2007",
month = "7",
doi = "10.2174/157016207781023974",
language = "English",
volume = "5",
pages = "403--409",
journal = "Current HIV Research",
issn = "1570-162X",
publisher = "Bentham Science Publishers",
number = "4",

}

TY - JOUR

T1 - Oncogenic properties of HIV-tat in colorectal cancer cells

AU - Huynh, Duy

AU - Vincan, Elizabeth

AU - Mantamadiotis, Theo

AU - Purcell, Damian

AU - Chan, Chee Kai

AU - Ramsay, Robert

PY - 2007/7

Y1 - 2007/7

N2 - With the advent of Highly-Active-Anti-Retroviral-Therapy (HAART), HIV patients can expect to live beyond 10-15 years following diagnosis. An unexpected result of increased survival is the emergence of opportunistic, oncogenic virus-associated cancers such as Burkitt's lymphoma (Epstein-Barr Virus), cervical cancer (Human Papilloma Virus) and Kaposi's sarcoma (Kaposi's sarcoma-associated herpesvirus) in this immuno-compromised population. Furthermore, there are reports of colorectal cancers (CRC) in long-term HIV-AIDS survivors. Compared to the general, non-immunocompromised population, long-term AIDS patients have 4 and 3.3-fold increased risk of developing colorectal and anorectal cancer respectively. Unlike oncogenic virus-associated cancers, CRC is not known to have a viral etiology. Our study aimed to investigate one aspect of HIV infection and colorectal carcinogenesis. We proposed that the HIV transactivator protein Tat; a protein with known oncogenic properties that is secreted and can re-enter non-infected cells may have a role in CRC. Using two CRC cell lines, LIM1215 and LIM2537 we found that Tat inhibits epithelial cyto-differentiation, blocks apoptosis in vitro and accelerates tumour formation in vivo. In addition, Tat significantly increases in vitro migration in the absence of foetal calf serum. These properties underpin CRC, and as HIV infection is initiated in the gut lymphoid system, these data provide a basis for the increased incidence of CRC in long term AIDS patients.

AB - With the advent of Highly-Active-Anti-Retroviral-Therapy (HAART), HIV patients can expect to live beyond 10-15 years following diagnosis. An unexpected result of increased survival is the emergence of opportunistic, oncogenic virus-associated cancers such as Burkitt's lymphoma (Epstein-Barr Virus), cervical cancer (Human Papilloma Virus) and Kaposi's sarcoma (Kaposi's sarcoma-associated herpesvirus) in this immuno-compromised population. Furthermore, there are reports of colorectal cancers (CRC) in long-term HIV-AIDS survivors. Compared to the general, non-immunocompromised population, long-term AIDS patients have 4 and 3.3-fold increased risk of developing colorectal and anorectal cancer respectively. Unlike oncogenic virus-associated cancers, CRC is not known to have a viral etiology. Our study aimed to investigate one aspect of HIV infection and colorectal carcinogenesis. We proposed that the HIV transactivator protein Tat; a protein with known oncogenic properties that is secreted and can re-enter non-infected cells may have a role in CRC. Using two CRC cell lines, LIM1215 and LIM2537 we found that Tat inhibits epithelial cyto-differentiation, blocks apoptosis in vitro and accelerates tumour formation in vivo. In addition, Tat significantly increases in vitro migration in the absence of foetal calf serum. These properties underpin CRC, and as HIV infection is initiated in the gut lymphoid system, these data provide a basis for the increased incidence of CRC in long term AIDS patients.

KW - Colon cancer

KW - HAART

KW - HIV-1

KW - Oncogene

KW - Tat

UR - http://www.scopus.com/inward/record.url?scp=34447260283&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34447260283&partnerID=8YFLogxK

U2 - 10.2174/157016207781023974

DO - 10.2174/157016207781023974

M3 - Article

C2 - 17627503

AN - SCOPUS:34447260283

VL - 5

SP - 403

EP - 409

JO - Current HIV Research

JF - Current HIV Research

SN - 1570-162X

IS - 4

ER -